Is Hepatitis Delta infections important in Brazil?

por Cicero, Maira Ferreira, Pena, Nathalia Mantovani, Santana, Luiz Claudio, Arnold, Rafael, Azevedo, Rafael Gonçalves, Leal, Élcio de Souza, Diaz, Ricardo Sobhie, Komninakis, Shirley Vasconcelos
Publicado 2016

Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial

por de Almeida Baptista, Marcella Vassão, da Silva, Laís Teodoro, Samer, Sadia, Oshiro, Telma Miyuki, Shytaj, Iart Luca, Giron, Leila B., Pena, Nathalia Mantovani, Cruz, Nicolly, Gosuen, Gisele Cristina, Ferreira, Paulo Roberto Abrão, Cunha-Neto, Edécio, Galinskas, Juliana, Dias, Danilo, Sucupira, Maria Cecilia Araripe, de Almeida-Neto, Cesar, Salomão, Reinaldo, da Silva Duarte, Alberto José, Janini, Luís Mário, Hunter, James R., Savarino, Andrea, Juliano, Maria Aparecida, Diaz, Ricardo Sobhie
Publicado 2022